Diverse intratumoral heterogeneity and immune microenvironment of two HPV‐related cervical cancer types revealed by single‐cell RNA sequencing

Cervical squamous cell carcinoma (SCC) and adenocarcinoma (AD) are the main histological types of human papillomavirus‐related cervical cancer. However, there are few reports on cell type‐specific molecular differences between SCC and AD. Here, we used unbiased droplet‐based single‐cell RNA sequencing to elucidate the cellular differences between SCC and AD in tumor heterogeneity, and tumor microenvironment (TME). A total of 61 723 cells from three SCC and three AD patients, were collected and divided into nine cell types. Epithelial cells exhibited high intra‐ and interpatient heterogeneity and functional diversity. Signaling pathways, such as epithelial‐to‐mesenchymal‐transition (EMT), hypoxia and inflammatory response were upregulated in SCC, while cell cycle‐related signaling pathways were highly enriched in AD. SCC was associated with high infiltration of cytotoxicity CD8 T, effector memory CD8 T, proliferative natural killer (NK), and CD160+ NK cells as well as tumor‐associated macrophages (TAMs) with high major histocompatibility complex‐II genes. AD exhibited a high proportion of naive CD8 T, naive CD4 T, Treg CD4, central memory CD8, and TAMs with immunomodulatory functions. Additionally, we also observed that the majority of cancer‐associated fibroblasts (CAFs) were from AD, and participated in inflammation regulation, while SCC‐derived CAFs exhibited similar functions to tumor cells, such as EMT and hypoxia. This study revealed the widespread reprogramming of multiple cell populations in SCC and AD, dissected the cellular heterogeneity and characteristics in TME, and proposed potential therapeutic strategies for CC, such as targeted therapy and immunotherapy.

[1]  J. Yue,et al.  Single‐cell transcriptomics dissects epithelial heterogeneity in HPV+ cervical adenocarcinoma , 2023, Journal of medical virology.

[2]  Y. Ni,et al.  Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression , 2023, Science advances.

[3]  Q. Hu,et al.  Immune landscape of viral cancers: Insights from single‐cell sequencing , 2022, Journal of medical virology.

[4]  Wen-Lu Zou,et al.  Single‐cell RNA‐sequencing dissects cellular heterogeneity and identifies two tumor‐suppressing immune cell subclusters in HPV‐related cervical adenosquamous carcinoma , 2022, Journal of medical virology.

[5]  V. Boussiotis,et al.  The complex role of tumor-infiltrating macrophages , 2022, Nature Immunology.

[6]  Ming Li,et al.  Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review , 2022, Journal of Experimental & Clinical Cancer Research.

[7]  Chunbo Li,et al.  Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes , 2022, Frontiers in Immunology.

[8]  D. Tang,et al.  Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition , 2022, Clinical Medicine Insights. Oncology.

[9]  Chen Liang,et al.  Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives , 2021, Molecular Cancer.

[10]  K. Murphy,et al.  Dendritic cells in cancer immunology , 2021, Cellular & molecular immunology.

[11]  S. Godina-González,et al.  Understanding Cervical Cancer through Proteomics , 2021, Cells.

[12]  G. Freeman,et al.  Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade. , 2021, Molecular cell.

[13]  K. Hua,et al.  Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC , 2021, Molecular therapy. Nucleic acids.

[14]  M. Oliveira,et al.  The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment. , 2021, Cytokine & growth factor reviews.

[15]  D. Zheng,et al.  Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance , 2021, Clinical Cancer Research.

[16]  M. Haigis,et al.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism , 2021, Nature Metabolism.

[17]  P. Dzięgiel,et al.  CCL18 in the Progression of Cancer , 2020, International journal of molecular sciences.

[18]  S. Hugues,et al.  Lymph Node Stromal Cells: Mapmakers of T Cell Immunity , 2020, International journal of molecular sciences.

[19]  Dakang Xu,et al.  Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment , 2020, Frontiers in Immunology.

[20]  Zhaowu Ma,et al.  Dendritic cell biology and its role in tumor immunotherapy , 2020, Journal of Hematology & Oncology.

[21]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[22]  S. Teichmann,et al.  Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth , 2020, Cell reports.

[23]  H. Ghanbarian,et al.  Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy , 2020, Expert opinion on drug delivery.

[24]  Yunbao Pan,et al.  Immune checkpoint: The novel target for antitumor therapy , 2019, Genes & diseases.

[25]  Hui Xie,et al.  Expression and function of FRA1 protein in tumors , 2019, Molecular Biology Reports.

[26]  Xianwen Ren,et al.  Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.

[27]  Nicole M. Chapman,et al.  Metabolic coordination of T cell quiescence and activation , 2019, Nature Reviews Immunology.

[28]  P. Romero,et al.  Navigating metabolic pathways to enhance antitumour immunity and immunotherapy , 2019, Nature Reviews Clinical Oncology.

[29]  H. Nishikawa,et al.  Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? , 2019, Cancer science.

[30]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[31]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[32]  M. Smyth,et al.  Cancer immunoediting and resistance to T cell-based immunotherapy , 2018, Nature Reviews Clinical Oncology.

[33]  A. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[34]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[35]  M. Najafi,et al.  Cancer‐associated fibroblasts: Secretions, interactions, and therapy , 2018, Journal of cellular biochemistry.

[36]  O. Awolude,et al.  Cervical cancer worldwide. , 2018, Current problems in cancer.

[37]  J. Sáez-Rodríguez,et al.  Benchmark and integration of resources for the estimation of human transcription factor activities , 2018, bioRxiv.

[38]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[39]  J. Borghans,et al.  The full spectrum of human naive T cells , 2018, Nature Reviews Immunology.

[40]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[41]  Boxi Kang,et al.  Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing , 2017, Cell.

[42]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy , 2016, Cell Research.

[43]  B. Ruffell,et al.  Dendritic Cells and Cancer Immunity. , 2016, Trends in immunology.

[44]  Xi Cheng,et al.  Advances in diagnosis and treatment of metastatic cervical cancer , 2016, Journal of gynecologic oncology.

[45]  Lingyi Chen,et al.  Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells , 2015, PloS one.

[46]  J. Schenkel,et al.  Tissue-resident memory T cells. , 2014, Immunity.

[47]  Y. Hashiguchi,et al.  Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I-II cervical cancer. , 2014, Molecular and clinical oncology.

[48]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[49]  J. Parkhurst,et al.  Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks , 2013, Global public health.

[50]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[51]  F. Rahbarizadeh,et al.  Generation of In-vitro Spermatogonial Stem Cells following Genetic Manipulation of Primordial Germ-like Cells , 2012, Avicenna journal of medical biotechnology.

[52]  M. Seoud,et al.  Cervical adenocarcinoma: moving towards better prevention. , 2011, Vaccine.

[53]  S. Pirino,et al.  Characterization, isolation and culture of primordial germ cells in domestic animals: recent progress and insights from the ovine species. , 2010, Theriogenology.

[54]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[55]  Michael C. Schmid,et al.  Myeloid cell trafficking and tumor angiogenesis. , 2007, Cancer letters.

[56]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[57]  J. Talmadge,et al.  Tumor Immuno-Environment in Cancer Progression and Therapy. , 2017, Advances in experimental medicine and biology.

[58]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[59]  G. Thomas,et al.  Adenocarcinoma: a unique cervical cancer. , 2010, Gynecologic oncology.

[60]  R. Salter,et al.  Dendritic cells in cancer , 2009 .

[61]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.